About the Corporation
Year display
category
[First in Japan*] Successful surgery using AI system "Eureka α"
The 39th to 41st Hanshin Railway Health Seminars (free to participate) will be held
Confirmation that liquid biopsy is useful for deciding on adjuvant therapy after surgery for colorectal cancer liver metastases
Shimadzu and the Company have developed a new method for evaluating ulcerative colitis: Quantitative evaluation of disease state from blood dye concentration using a liquid chromatography mass spectrometer
Notice of personnel changes
[April 2025] Doctoral programs to be established in the Graduate Graduate School of Nursing and Graduate School of Rehabilitation Science
Hyogo Medical University and Sumoto City, Hyogo Prefecture, sign agreement to promote the health of citizens and revitalize the local community
Started joint research with G-One Inc. to develop AI model for diagnostic support of inflammatory bowel disease
Our University Doctors Begin Development of AI to Support Appropriate Use of Anticancer Drugs as an Industry-Academia Collaboration Project with the Lung Cancer Society
Released a free app called "Fuasil" with emol Inc. to raise awareness of obsessive-compulsive disorder and social anxiety disorder
CT images can predict delays in regaining independent walking after cardiovascular surgery - Potential to be useful in determining suitability for preoperative treatment intervention
Japan's only correspondence health course holds "physical fitness test (offline meet-up)" exclusively for participants - a new platform for nursing care prevention
Successful accurate visualization of the internal iliac vein to reduce the risk of bleeding during surgery for local recurrence of rectal cancer - Multidisciplinary research by radiologists and surgeons -
Nationwide survey conducted on exercise instruction for hemodialysis patients after changes to insurance system
Our dental technician received the 31st Hyogo Prefecture Dental Health Culture Merit Award.
Hyogo Medical University and Hyogo Ward, Kobe City, enter into a partnership agreement
Selected for the Ministry of the Environment's "Comprehensive Research on PFAS" (FY2024) - Elucidating the immunosuppressive and immunostimulatory effects of PFAS in immune diseases
Multidisciplinary collaboration results in the publication of a paper on postoperative subcutaneous emphysema following laparoscopic surgery
Announcement of presentation of research results on eNK® cells for mesothelioma at the American Association for Cancer Research Annual Meeting (AACR Annual Meeting 2024)